ASHMAN CLAIRE has a total of 12 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are TALIGEN THERAPEUTICS INC, DOMANTIS LTD and ANAPTYSBIO INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Ashman Claire | 12 |
#2 | Ellis Jonathan Henry | 6 |
#3 | Orecchia Martin Anibal | 5 |
#4 | Steward Michael | 4 |
#5 | Lewis Alan Peter | 4 |
#6 | Hamblin Paul Andrew | 4 |
#7 | Lewis Alan | 3 |
#8 | Ellis Jonathan H | 2 |
#9 | Batuwangala Thil | 2 |
#10 | Hussain Farhana | 2 |
Publication | Filing date | Title |
---|---|---|
US2009148905A1 | Antigen-binding constructs | |
US2006104943A1 | Vaccine comprising il-13 and an adjuvant | |
AU2003259358A8 | Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |